Janré Steyn
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Janré Steyn has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
Alina Nalyvayko
Division of Pulmonary and Critical Care Medicine, Zuckerberg San Francisco General Hospital and Trauma Centre, University of California San Francisco, San Francisco, CA, USA
3 shared publications- Christoffel Johannes Opperman
National Health Laboratory Service, Green Point TB-Laboratory, Cape Town, South Africa; Division of Molecular Biology and Human Genetics, Stellenbosch University, Cape Town, South Africa; Division of Medical Microbiology, Department of Pathology, University of Cape Town, Cape Town, South Africa
3 shared publications Melanie Grobbelaar
SAMRC Centre for Tuberculosis Research, DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa
3 shared publications- Wynand Johan Goosen
University of the Free State
3 shared publications Yonas Ghebrekristos
SAMRC Centre for Tuberculosis Research, DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa; National Health Laboratory Service, Greenpoint TB-Laboratory, Cape Town, South Africa
3 shared publicationsAliasgar Esmail
University of Cape Town Lung Institute, Centre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa
2 shared publications
Latest Publications
- Top Cited PapersOpen Access
- 19 February 2026
- Published by Elsevier in The Lancet Microbe
- Vol. 7 (3) , 101293
Bedaquiline resistance in patients with Xpert MTB/RIF Ultra-tested rifampicin-resistant tuberculosis in the Western Cape, South Africa: a prospective study
- 19 February 2026
- Published by Elsevier in The Lancet Microbe
- Vol. 7 (3) , 101293
Top Cited PapersOpen AccessBedaquiline resistance in patients with Xpert MTB/RIF Ultra-tested rifampicin-resistant tuberculosis in the Western Cape, South Africa: a prospective study
- Open Access
- 3 April 2025
- Published by Springer Nature
Bead Beating in Custom Buffer Followed by XP Bead Cleanup (NGS Workflow) v1
DNA extraction method for Mycobacterium tuberculosis from various sample types as described in: "Insights into Mycobacterium tuberculosis DNA extraction for targeted deep sequencing using the Deeplex Myc-TB assay: Lessons for improved drug resistance diagnosis."
- 3 April 2025
- Published by Springer Nature
Open AccessBead Beating in Custom Buffer Followed by XP Bead Cleanup (NGS Workflow) v1
DNA extraction method for Mycobacterium tuberculosis from various sample types as described in: "Insights into Mycobacterium tuberculosis DNA extraction for targeted deep sequencing using the Deeplex Myc-TB assay: Lessons for improved drug resistance diagnosis."
- Open Access
- 1 January 2025
- Published by AOSIS in Southern African Journal of Infectious Diseases
- Vol. 40 (1) , 5
Mycobacterium avium DNA extraction: Implications for NTM identification and amplicon sequencing
This study evaluated six DNA (Deoxyribonucleic acid) extraction methods for Mycobacterium avium, focusing on cost, procedure time, yield, quality, DNA integrity, and suitability for amplicon-based sequencing. The extracted DNA was used in the GenoType® Mycobacterium Common Mycobacterium (CM) line probe assay (LPA), which is routinely used for nontuberculous mycobacteria (NTM) identification in South Africa. Contribution: The findings demonstrate that the currently used DNA extraction method, GenoLyse® Version 1.0, remains the fastest, simplest, and most cost-effective approach for routine NTM identification, despite lower DNA yields. GenoLyse also shows potential for implementation in amplicon-based sequencing of NTM, specifically when amplifying the 16S rRNA gene.
- 1 January 2025
- Published by AOSIS in Southern African Journal of Infectious Diseases
- Vol. 40 (1) , 5
Open AccessMycobacterium avium DNA extraction: Implications for NTM identification and amplicon sequencing
This study evaluated six DNA (Deoxyribonucleic acid) extraction methods for Mycobacterium avium, focusing on cost, procedure time, yield, quality, DNA integrity, and suitability for amplicon-based sequencing. The extracted DNA was used in the GenoType® Mycobacterium Common Mycobacterium (CM) line probe assay (LPA), which is routinely used for nontuberculous mycobacteria (NTM) identification in South Africa. Contribution: The findings demonstrate that the currently used DNA extraction method, GenoLyse® Version 1.0, remains the fastest, simplest, and most cost-effective approach for routine NTM identification, despite lower DNA yields. GenoLyse also shows potential for implementation in amplicon-based sequencing of NTM, specifically when amplifying the 16S rRNA gene.
- Open Access
- 29 November 2024
- Published by Elsevier in IJID Regions
- Vol. 14, 100502
Mixed nontuberculous mycobacteria in an immunocompromised patient with probable progressive multifocal leukoencephalopathy
- 29 November 2024
- Published by Elsevier in IJID Regions
- Vol. 14, 100502
Open AccessMixed nontuberculous mycobacteria in an immunocompromised patient with probable progressive multifocal leukoencephalopathy
- Open Access
- 24 September 2024
- Published by Elsevier in IJID Regions
- Vol. 13, 100464
Targeted deep sequencing of mycobacteria species from extrapulmonary sites not identified by routine line probe assays: A retrospective laboratory analysis of stored clinical cultures
- 24 September 2024
- Published by Elsevier in IJID Regions
- Vol. 13, 100464
Open AccessTargeted deep sequencing of mycobacteria species from extrapulmonary sites not identified by routine line probe assays: A retrospective laboratory analysis of stored clinical cultures
- Open Access
- 5 May 2023
- Published by Springer Nature
Bead Beating in Custom Buffer Followed by XP Bead Cleanup (NGS Workflow) v1
DNA extraction method for Mycobacterium tuberculosis from various sample types as described in: "Insights into Mycobacterium tuberculosis DNA extraction for targeted deep sequencing using the Deeplex Myc-TB assay: Lessons for improved drug resistance diagnosis."
- 5 May 2023
- Published by Springer Nature
Open AccessBead Beating in Custom Buffer Followed by XP Bead Cleanup (NGS Workflow) v1
DNA extraction method for Mycobacterium tuberculosis from various sample types as described in: "Insights into Mycobacterium tuberculosis DNA extraction for targeted deep sequencing using the Deeplex Myc-TB assay: Lessons for improved drug resistance diagnosis."
- 1 May 2018
- Published by Wolters Kluwer Health in Sexually Transmitted Diseases
- Vol. 45 (5) , 332-336
Prevalence and Detection of Trichomonas vaginalis in HIV-Infected Pregnant Women
Background: Trichomonas vaginalis is a sexually transmitted infection associated with increased transmission of HIV and significant adverse birth outcomes; culture and polymerase chain reaction (PCR) are commonly used in diagnosis. Methods: Consenting HIV-infected pregnant women were recruited from clinics in South Africa and screened for T. vaginalis using PCR. Polymerase chain reaction–positive women provided an additional sample for culture. We compared T. vaginalis detection between PCR and culture, and investigated how PCR cycle threshold (Ct) values differ among culture results. Results: A total of 359 women were enrolled and 76 (20%) tested T. vaginalis PCR positive. Cultures were obtained from 61 of the PCR-positive women, and 38 (62%) were culture positive. The median baseline Ct of the PCR-positive/culture-positive group was 22.6 versus 38.0 among those who were PCR positive/culture negative (P < 0.001). Culture-positive cases had lower Ct values (higher DNA load); a Ct value less than 30 predicted positivity with a sensitivity of 97% and a specificity of 96%. Conclusions: Culture was positive in roughly half of PCR-positive cases. The culture-negative cases had significantly higher Ct values, indicating a lower concentration of T. vaginalis DNA. A Ct value of 30 provides a reliable threshold for predicting culture positivity. The clinical significance of culture-negative infections detected by PCR is still unclear.
- 1 May 2018
- Published by Wolters Kluwer Health in Sexually Transmitted Diseases
- Vol. 45 (5) , 332-336
Prevalence and Detection of Trichomonas vaginalis in HIV-Infected Pregnant Women
Background: Trichomonas vaginalis is a sexually transmitted infection associated with increased transmission of HIV and significant adverse birth outcomes; culture and polymerase chain reaction (PCR) are commonly used in diagnosis. Methods: Consenting HIV-infected pregnant women were recruited from clinics in South Africa and screened for T. vaginalis using PCR. Polymerase chain reaction–positive women provided an additional sample for culture. We compared T. vaginalis detection between PCR and culture, and investigated how PCR cycle threshold (Ct) values differ among culture results. Results: A total of 359 women were enrolled and 76 (20%) tested T. vaginalis PCR positive. Cultures were obtained from 61 of the PCR-positive women, and 38 (62%) were culture positive. The median baseline Ct of the PCR-positive/culture-positive group was 22.6 versus 38.0 among those who were PCR positive/culture negative (P < 0.001). Culture-positive cases had lower Ct values (higher DNA load); a Ct value less than 30 predicted positivity with a sensitivity of 97% and a specificity of 96%. Conclusions: Culture was positive in roughly half of PCR-positive cases. The culture-negative cases had significantly higher Ct values, indicating a lower concentration of T. vaginalis DNA. A Ct value of 30 provides a reliable threshold for predicting culture positivity. The clinical significance of culture-negative infections detected by PCR is still unclear.
- 8 July 2017
- Published by BMJ
- Vol. 93, A49-A50
P1.15 Trichomonas vaginalisin human immunodeficiency virus-infected pregnant women: prevalence, detection, and application of pcr cycle-threshold values
Introduction: Trichomonas vaginalis (TV) is a sexually transmitted infection (STI) associated with increased transmission of human immunodeficiency virus (HIV) and significant adverse birth outcomes. Although culture is often used in the diagnosis of TV, molecular diagnosis is rapid, accurate, and data-rich. Methods Women were recruited from two clinics in South Africa as part of a study assessing point-of-care polymerase chain reaction (PCR) diagnosis and treatment of three STIs. HIV-infected pregnant women were screened for TV using the Xpert TV (Cepheid, Sunnyvale, CA). Each woman who tested TV PCR-positive provided an additional sample for culture (InPouch TV, Biomed, San Jose, CA). We compared TV detection between PCR and culture, and used non-parametric statistics to compare cycle threshold (Ct) values among culture results and treatment outcomes. Results By December 31st, 2016, 200 women were enrolled and 52 (26%) tested TV PCR-positive. Baseline cultures were obtained from 41 (79%) of the TV PCR-positive women, and 22 (54%) were culture-positive. The median baseline Ct of the TV PCR-positive/culture-positive group was 24.0 (IQR: 5.1) vs. 38.0 (IQR: 3.8) among those TV PCR-positive/culture-negative (p0.05). Conclusion The prevalence of TV in our sample of South African HIV-infected pregnant women was similar to prior studies. At baseline, culture detected only half of the cases that were positive by TV PCR. The culture-negative cases had significantly higher Ct values, indicating a lower burden of TV nucleic acid. Baseline Ct values did not predict response to TV treatment. Among women testing persistently TV PCR-positive, Ct values did not change between baseline and ToC.
- 8 July 2017
- Published by BMJ
- Vol. 93, A49-A50
P1.15 Trichomonas vaginalisin human immunodeficiency virus-infected pregnant women: prevalence, detection, and application of pcr cycle-threshold values
Introduction: Trichomonas vaginalis (TV) is a sexually transmitted infection (STI) associated with increased transmission of human immunodeficiency virus (HIV) and significant adverse birth outcomes. Although culture is often used in the diagnosis of TV, molecular diagnosis is rapid, accurate, and data-rich. Methods Women were recruited from two clinics in South Africa as part of a study assessing point-of-care polymerase chain reaction (PCR) diagnosis and treatment of three STIs. HIV-infected pregnant women were screened for TV using the Xpert TV (Cepheid, Sunnyvale, CA). Each woman who tested TV PCR-positive provided an additional sample for culture (InPouch TV, Biomed, San Jose, CA). We compared TV detection between PCR and culture, and used non-parametric statistics to compare cycle threshold (Ct) values among culture results and treatment outcomes. Results By December 31st, 2016, 200 women were enrolled and 52 (26%) tested TV PCR-positive. Baseline cultures were obtained from 41 (79%) of the TV PCR-positive women, and 22 (54%) were culture-positive. The median baseline Ct of the TV PCR-positive/culture-positive group was 24.0 (IQR: 5.1) vs. 38.0 (IQR: 3.8) among those TV PCR-positive/culture-negative (p0.05). Conclusion The prevalence of TV in our sample of South African HIV-infected pregnant women was similar to prior studies. At baseline, culture detected only half of the cases that were positive by TV PCR. The culture-negative cases had significantly higher Ct values, indicating a lower burden of TV nucleic acid. Baseline Ct values did not predict response to TV treatment. Among women testing persistently TV PCR-positive, Ct values did not change between baseline and ToC.